DrugPatentWatch Database Preview
Drugs in Development Information for Pyridoxamine
Join the DrugPatentWatch Referral Program Get access to a free drug patent landscape report or a free one-month subscription
What is the drug development status for Pyridoxamine?
Pyridoxamine is an investigational drug.
There have been 6 clinical trials for Pyridoxamine.
The most recent clinical trial was a Phase 2 trial, which was initiated on June 1st 2014.
The most common disease conditions in clinical trials are Diabetic Nephropathies, Kidney Diseases, and Diabetes Mellitus, Type 2. The leading clinical trial sponsors are BioStratum, NephroGenex, Inc., and Medpace, Inc.
There is one US patent protecting this investigational drug and ten international patents.
Summary for Pyridoxamine
| US Patents | 1,295 |
| International Patents | 10,801 |
| US Patent Applications | 2,602 |
| WIPO Patent Applications | 1,545 |
| Japanese Patent Applications | 13 |
| Clinical Trial Progress | Phase 2 (2014-06-01) |
| Vendors | 35 |
Recent Clinical Trials for Pyridoxamine
| Title | Sponsor | Phase |
|---|---|---|
| Advanced Glycation Endproducts and Bone Material Strength in T2D Treated With Pyridoxamine | Columbia University | N/A |
| Pyridorin in Diabetic Nephropathy | Collaborative Study Group (CSG) | Phase 3 |
| Pyridorin in Diabetic Nephropathy | Medpace, Inc. | Phase 3 |
Clinical Trial Summary for Pyridoxamine
Top disease conditions for Pyridoxamine
Top clinical trial sponsors for Pyridoxamine
US Patents for Pyridoxamine
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
|---|---|---|---|---|
| Pyridoxamine | Start Trial | Lipid compositions comprising triacylglycerol with long-chain polyunsaturated fatty acids at the sn-2 position | COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION (Acton, AU) GRAINS RESEARCH AND DEVELOPMENT CORPORATION (Barton, AU) NUSEED PTY LTD. (Laverton North, AU) | Start Trial |
| Pyridoxamine | Start Trial | Compounds useful for the treatment of metabolic disorders and synthesis of the same | North Carolina Central University (Durham, NC) The University of North Carolina at Chapel Hill (Chapel Hill, NC) | Start Trial |
| Pyridoxamine | Start Trial | Particle detecting device | AZBIL CORPORATION (Chiyoda-ku, JP) | Start Trial |
| Pyridoxamine | Start Trial | Compositions and methods useful for ameliorating age related maladies | NestecSA (Vevey, CH) | Start Trial |
| Pyridoxamine | Start Trial | Nutritional composition for promoting gut microbiota balance and health | Nestec S.A. (Vevey, CH) | Start Trial |
| Pyridoxamine | Start Trial | Fused heterocyclic compound | Takeda Pharmaceutical Company Limited (Osaka, JP) | Start Trial |
| Pyridoxamine | Start Trial | Heterocyclic compound | Takeda Pharmaceutical Company Limited (Tokyo, JP) | Start Trial |
| >Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
International Patents for Pyridoxamine
| Drugname | Country | Document Number | Estimated Expiration | Related US Patent |
|---|---|---|---|---|
| Pyridoxamine | Argentina | 098831 | 2033-12-18 | Start Trial |
| Pyridoxamine | Australia | 2014366839 | 2033-12-18 | Start Trial |
| Pyridoxamine | Australia | 2015281791 | 2033-12-18 | Start Trial |
| Pyridoxamine | Brazil | 112016014508 | 2033-12-18 | Start Trial |
| Pyridoxamine | Brazil | 112016030705 | 2033-12-18 | Start Trial |
| Pyridoxamine | Canada | 2933909 | 2033-12-18 | Start Trial |
| Pyridoxamine | Canada | 2953008 | 2033-12-18 | Start Trial |
| >Drugname | >Country | >Document Number | >Estimated Expiration | >Related US Patent |
